Analysis of the substrate recognition domain determinants of Botulinum Type B toxin using Phage Display

被引:9
作者
Evans, ER
Sutton, JM
Gravett, A
Shone, CC
机构
[1] Hlth Protect Agcy, Ctr Emergency Preparedness & Response, Salisbury SP4 0JG, Wilts, England
[2] Univ Bath, Dept Biol, Bath BA2 7AY, Avon, England
关键词
phage display; Clostridium botulinum neurotoxin type B; VAMP; SNARE motif;
D O I
10.1016/j.toxicon.2005.06.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The botulinum neurotoxin endopeptidases appear to recognise their intracellular protein substrates via two distinct sites: the cleavage site sequence and a 'recognition site' motif. In the present study phage display has been employed to generate a library of vesicle-associated membrane protein (VAMP2) variants in which the toxin recognition motif (part of the SNARE motif ELDDRADA) has been modified. VAMP (1-94) was displayed on the surface of M13 bacteriophage and this fragment was recognised and cleaved by botulinum neurotoxin type B (BoNT/B). A phage-displayed library was constructed in which six residues of the recognition domain (VAMP residues 63-68; wild-type sequence LDDRAD) were randomised, and a selection method established for identifying cleaved VAMP variants. Sequence analysis of 24 clones revealed that 5 contained two acidic residues although none corresponded to the native sequence. Cleavage was reduced compared to wild-type VAMP, and cleavage of mutants containing no acidic residues was also observed. The data are discussed in relation to the substrate recognition mechanism of BoNT/B. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:446 / 453
页数:8
相关论文
共 24 条
[1]   BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].
BLASI, J ;
CHAPMAN, ER ;
LINK, E ;
BINZ, T ;
YAMASAKI, S ;
DECAMILLI, P ;
SUDHOF, TC ;
NIEMANN, H ;
JAHN, R .
NATURE, 1993, 365 (6442) :160-163
[2]  
BRELDENBACH MA, 2004, NATURE, V432, P925
[3]   ACCEPTORS FOR BOTULINUM NEUROTOXIN RESIDE ON MOTOR-NERVE TERMINALS AND MEDIATE ITS INTERNALIZATION [J].
DOLLY, JO ;
BLACK, J ;
WILLIAMS, RS ;
MELLING, J .
NATURE, 1984, 307 (5950) :457-460
[4]   Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities [J].
Hallis, B ;
James, BAF ;
Shone, CC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (08) :1934-1938
[5]   RETRACTED: Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 Å resolution (Retracted article. See vol 16, pg 795, 2009) [J].
Hanson, MA ;
Stevens, RC .
NATURE STRUCTURAL BIOLOGY, 2000, 7 (08) :687-692
[6]   BY-PASSING IMMUNIZATION - HUMAN-ANTIBODIES FROM SYNTHETIC REPERTOIRES OF GERMLINE VH GENE SEGMENTS REARRANGED INVITRO [J].
HOOGENBOOM, HR ;
WINTER, G .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 227 (02) :381-388
[7]  
NIEMANN H, 1991, SOURCEBOOK BACTERIAL, P303
[8]   ANTIBODY FRAGMENTS FROM A SINGLE POT PHAGE DISPLAY LIBRARY AS IMMUNOCHEMICAL REAGENTS [J].
NISSIM, A ;
HOOGENBOOM, HR ;
TOMLINSON, IM ;
FLYNN, G ;
MIDGLEY, C ;
LANE, D ;
WINTER, G .
EMBO JOURNAL, 1994, 13 (03) :692-698
[9]  
Nixon Andrew E., 2002, Current Pharmaceutical Biotechnology, V3, P1
[10]   Identification of substrate sequences for membrane type-1 matrix metalloproteinase using bacteriophage peptide display library [J].
Ohkubo, S ;
Miyadera, K ;
Sugimoto, Y ;
Matsuo, K ;
Wierzba, K ;
Yamada, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (02) :308-313